title: [Venlafaxine-induced delirium mediated by high doses].
authors.affiliation: Hospital Provincial de Conxo, Santiago de Compostela, Espana.
authors.forename: Lucía
authors.initials: L
authors.lastname: del Río-Casanova
authors.forename: Begoña
authors.initials: B
authors.lastname: Portela
authors.forename: Francisco
authors.initials: F
authors.lastname: Díaz-Llenderrozas
mesh_terms: D000368:Aged; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D015897:Comorbidity; D003221:Confusion / Q000139:chemically induced; D003693:Delirium / Q000139:chemically induced* / Q000188:drug therapy; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004298:Dopamine / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D057915:Drug Substitution; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D008959:Models, Neurological; D009638:Norepinephrine / Q000502:physiology; D019338:Polypharmacy; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D020280:Sertraline / Q000493:pharmacokinetics / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D000928:Antidepressive Agents; D011619:Psychotropic Drugs; D000069470:Venlafaxine Hydrochloride; D008140:Lorazepam; D020280:Sertraline; D004298:Dopamine; D009638:Norepinephrine